Louisiana 2016 Regular Session

Louisiana Senate Bill SB284

Introduced
3/4/16  
Introduced
3/4/16  
Refer
3/4/16  
Refer
3/4/16  
Refer
3/14/16  

Caption

Prohibits the sale of infant formula or baby food that is stored in plastic containers, jars, or cans that contain bisphenol-A. (8/1/16)

Impact

If signed into law, SB284 will affect state regulations regarding food safety and consumer protection. By banning the sale of certain products with known hazardous materials, the bill enforces stricter safety measures in the market for baby food and infant formula. This legislative change aligns Louisiana with a growing trend among states emphasizing consumer safety, thereby fostering a safer environment for infants regarding the products they consume. The amendment underscores a heightened awareness of chemical safety in consumer products, particularly those intended for children.

Summary

Senate Bill 284 seeks to enhance the safety standards of children's products by specifically prohibiting the sale of infant formula and baby food stored in plastic containers that contain bisphenol-A (BPA). BPA is a chemical often found in plastics, known for potentially harmful effects when it leaches into food. The proposed law aims to amend the existing Children's Product Safety Act, refining definitions and expanding the scope of what constitutes unsafe children's products. The bill is set to take effect on August 1, 2016, indicating a proactive approach to protecting vulnerable consumers, particularly infants and young children.

Sentiment

The sentiment surrounding SB284 is broadly supportive among child safety advocates and health organizations, as the bill addresses significant health concerns regarding BPA. However, some opposition may emerge from manufacturers and retailers who are concerned about the implications for their product lines and the associated financial burden of compliance. The necessity of safe products for children is generally agreed upon, but tensions exist regarding the economic impact on businesses and potential challenges in transitioning existing stock to comply with new regulations.

Contention

Notable points of contention have not been explicitly outlined within the discussions, but potential disagreements may arise over the effectiveness of banning BPA versus the costs of compliance for manufacturers. Critics may argue about possible unintended consequences, such as increased prices for consumers or difficulties in sourcing BPA-free alternatives. The bill may ignite a broader debate about regulatory approaches to food safety and the responsibilities of manufacturers versus the need to protect public health, particularly for the most vulnerable populations.

Companion Bills

No companion bills found.

Previously Filed As

LA HB683

Prohibits the sale of children's food containers that contain bisphenol-A

LA SB00915

An Act Concerning The Chemical Innovations Institute At The University Of Connecticut And The Prohibition On Bisphenol-a In Infant Formula And Baby Food Containers, Jars And Cans.

LA HB06798

An Act Requiring Labeling Of Baby Food And Infant Formula Containing Genetically Engineered Organisms.

LA HB853

Providing for bisphenol A-free container products for infants.

LA HB550

Providing for bisphenol A-free container products for infants.

LA S3109

Prohibits sale of unsafe supplemental mattresses designed for children's products.

LA HB1106

Exempt baby food, infant formula, and children's diapers from the state sales tax and state use tax.

LA A3865

Prohibits sale of crib bumpers.

LA A3750

Prohibits sale of crib bumpers.

LA SB3127

Sales tax; exempt sales of baby formula and baby diapers.

Similar Bills

NC H674

Child Advocacy Centers/Share Information

NM HB7

Children's Future Act & Fund

LA SB66

Provides relative to the Children's Cabinet and the Child Poverty Prevention Council of Louisiana. (8/1/17)

NJ A3800

Bans certain children's products containing excessive amounts of lead, mercury, or cadmium.

NJ A1525

Prohibits the sale of certain children's products containing lead, mercury, or cadmium.

NJ S1713

Prohibits the sale of certain children's products containing lead, mercury, or cadmium.

NJ A4952

Requires children's psychiatric facilities to have on-site staff members supervise patients 24 hours a day, seven days a week.

NJ A1571

Requires children's psychiatric facilities to have on-site staff members supervise patients 24 hours a day, seven days a week.